Publication | Open Access
Major adverse cardiovascular and limb events in people with diabetes treated with GLP-1 receptor agonists vs SGLT2 inhibitors
31
Citations
24
References
2022
Year
Metabolic SyndromeHypertensionDiabetes ManagementCardiovascular DiseaseMajor Adverse CardiovascularDiabetesPharmacologyLimb EventsDiabetes MellitusMedicineAtherosclerosisSglt2 Inhibitors
| Year | Citations | |
|---|---|---|
Page 1
Page 1